Diabetes drug tested to clear 'Brain Fog' in depression
NCT ID NCT04466345
Summary
This study tested whether adding the medication semaglutide to standard depression treatment could improve cognitive problems like poor memory and concentration. It involved 72 overweight adults with major depression who reported these thinking difficulties. Participants received either semaglutide or a placebo pill daily for 16 weeks while researchers measured changes in their mental sharpness.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Toronto Western Hospital
Toronto, Ontario, M5T 2S8, Canada
Conditions
Explore the condition pages connected to this study.